$CB

Morgan Stanley Adjusts Price Target on Chubb to $360 From $350

Morgan Stanley raised its price target for Chubb from $350 to $360. UBS also adjusted its target to $380 from $369, maintaining a neutral rating. Chubb's stock is currently trading at $357.40, up 0.65% on the day and 14.38% year-to-date.

Original reporting
Published Oct 26, 2026, 3:47 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 26, 2026, 4:16 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefFinancial news
Primary signal
$CB
Bullish
high confidence
Mentioned
$CB
Relevance
7/10
AlphAI data visualization · based on marketscreener.com
Decision brief

The 30-second read

$CBBullishMed
01

Why it matters

The higher target may attract new buying interest, but the effect could be muted if broader market sentiment is negative.

02

Market read

A modest analyst upgrade for a large‑cap insurer; likely limited but immediate impact on CB stock.

03

What to watch

Potential impact of upcoming regulatory changes on insurance pricing.

Relevance 7/10Novelty 7/10Timing: today

Background

Morgan Stanley updated its valuation model for Chubb, reflecting recent earnings and market conditions.

Company-level read

Ticker impact

$CBBullishHigh confidence
Context

Morgan Stanley raised Chubb's price target to $360 from $350.

Expected impact

potential upward pressure as investors price in the higher target.

Evidence & confidence

The target increase reflects improved outlook; market may react positively in the short term.

Market effects

May lift sentiment in the insurance sector as peers could see similar re‑ratings.

U.S. market could see modest buying in financials.

Limited to investors tracking large‑cap insurers.

Counterpoint

The target raise could be premature if underwriting risks rise.

Key entities

  • Morgan Stanley

    Equity research firm providing the price target update.

  • Chubb Limited

    U.S.-listed insurer (ticker CB) receiving the price target change.

Related articles

$CBHighAI 8/10

Chubb Ltd (CB) (Q3 2026) Earnings Call Highlights: Record Underwriting Income

Chubb Ltd (CB) reported Q3 2026 earnings with record core operating income of $2.98B ($7.66 per share) and underwriting income of $2.1B. Adjusted net investment income hit $1.89B. Growth was seen in Overseas General (6.7%) and international life insurance (15.5%). Challenges included North America Commercial premium decline (-2.7%) and $4.5B in net investment losses. CEO Evan Greenberg discussed AI liability, market competition, and growth opportunities in Asia.

$CBMedAI 8/10

Wells Fargo raises Chubb price target to $366, maintains Equal-Weight

Chubb Ltd reported Q2 adjusted EPS of $7.66, beating estimates by 12.48%, but missed revenue expectations with $13.183B. Wells Fargo raised its price target to $366, maintaining Equal-Weight. Cantor Fitzgerald kept a Neutral rating with a $333 target. Revenue grew 1.93% YoY, while underwriting income reached a record $5.8B.

$CBMed

Insurers ‘unlocking trillions’ for AI infrastructure

Insurers are providing capital for AI infrastructure like data centers and chip plants, according to Financial Times' Antoine Gara. Greg Crawford noted challenges in insuring AI data centers and highlighted Arbol's new parametric coverage. Chubb reported Q3 net income of $2.84B, up 4.4% YoY, with CEO Evan Greenberg warning of naive capital risks.

$CBHighAI 8/10

Chubb (CB) Q3 2026 Earnings Call Transcript

Chubb (CB) reported Q3 2026 core operating income of $8.6B, up 21% YoY, and core operating EPS of $21.94, up 24.5%. P&C underwriting income was $2.1B, with a combined ratio of 84.1%. Record investment income of $1.89B was driven by improved fixed income markets. The company expects continued growth and strong margins, with a focus on global diversification and rising interest rates.